Regeneron’s Post

View organization page for Regeneron, graphic

465,621 followers

The European Commission has approved our medicine for adults living with uncontrolled chronic obstructive pulmonary disease (#COPD), a respiratory disease that leads to exacerbations and causes progressive lung function decline and impaired quality of life. For a community that has not seen a new treatment approach in more than a decade, this marks an important step forward for those living with the disease in the EU. Read more about the news: https://bit.ly/3RPlLTW Sanofi

  • No alternative text description for this image

Congrats! important goal achieved

Like
Reply

Congrats! important goal achieved

Like
Reply
USA and international Research .

Chief Executive Officer at USA and International Research Inc.

1w

Fantastic news for the COPD community in the EU! This approval marks a significant advancement in treatment options after a decade.

Like
Reply
David R.

FSD Pharma Consultant - Biotech Investor - IR Services - Business Marketing - Social Media Management

1w

Congrats

Like
Reply
Ashwini Kumar Nangia (he/his)

Senior Professor at University of Hyderabad. PhD at Yale University

1w

Congratulations on bench to bedside translation

Like
Reply
Bruce Paolella

Principal Consultant Regulatory Affairs Opus Regulatory

1d

Fantastic

Like
Reply

Amazing treatment for COPD

Like
Reply
Jessica Auriana

Reimbursement | Market Access | Biologics | Injectables | Buy & Bill | Specialty Pharmacy | Immunology | Oncology

1w

Great news for patients!

Pamela (Pam) Bell

Sr. Recruiting Business Partner/Leader at Cognizant - HC&LS: Healthcare and Life Sciences: SALES - Client Partners, Client Relationship Managers and Account Executives - sales roles

1w

Awesome new for COPD patients! 😍

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics